Literature DB >> 18155159

Albumin suppresses vascular endothelial growth factor via alteration of hypoxia-inducible factor/hypoxia-responsive element pathway.

Pisut Katavetin1, Reiko Inagi, Toshio Miyata, Tetsuhiro Tanaka, Ryoji Sassa, Julie R Ingelfinger, Toshiro Fujita, Masaomi Nangaku.   

Abstract

Reduction of vascular endothelial growth factor (VEGF) expression plays a crucial role in chronic kidney disease (CKD). In order to clarify a cause of VEGF suppression in CKD, we examined an interaction between proteinuria and VEGF. Rat proximal tubular cells were subjected to hypoxia with or without albumin to mimic proteinuric conditions, and VEGF expression was assessed by real-time quantitative PCR and enzyme-linked immunosorbent assays. Albumin significantly reduced VEGF expression under hypoxia. Luciferase activity controlled by hypoxia-responsive element (HRE) was suppressed by albumin, demonstrating suppression of the hypoxia-inducible factor (HIF)/HRE pathway. Studies utilizing a proteasome inhibitor and a prolyl hydroxylase inhibitor showed that mechanisms of HIF/HRE pathway suppression by albumin load did not involve degradation of HIF protein levels. Further, albumin did not change HIF mRNA levels. Our data, for the first time, suggest a clear 'link' between proteinuria and hypoxia, the two principal pathogenic factors for CKD progression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18155159     DOI: 10.1016/j.bbrc.2007.12.086

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  TJ0711, a novel vasodilatory β-blocker, protects SHR rats against hypertension induced renal injury.

Authors:  Juan Yang; Yong Ning; Jun Qiu; Jin-Seng He; Wei Li; Zu-Fu Ma; Ju-Fang Shao; Yue-Qiang Li; Rui Zeng; Meng Zhang; Jia Cheng; Su-Fang Chen; Gang Xu; Cong-Yi Wang; Ying Yao
Journal:  Am J Transl Res       Date:  2013-04-19       Impact factor: 4.060

2.  Effect of Hachimijiogan against Renal Dysfunction and Involvement of Hypoxia-Inducible Factor-1α in the Remnant Kidney Model.

Authors:  Hiroshi Oka; Hirozo Goto; Keiichi Koizumi; Shin Nakamura; Koichi Tsuneyama; Yue Zhou; Michiko Jo; Takako Fujimoto; Hiroaki Sakurai; Naotoshi Shibahara; Ikuo Saiki; Yutaka Shimada
Journal:  Evid Based Complement Alternat Med       Date:  2011-02-24       Impact factor: 2.629

Review 3.  Capillary rarefaction, hypoxia, VEGF and angiogenesis in chronic renal disease.

Authors:  Gert Mayer
Journal:  Nephrol Dial Transplant       Date:  2011-02-17       Impact factor: 5.992

4.  Targeted iron-oxide nanoparticle for photodynamic therapy and imaging of head and neck cancer.

Authors:  Dongsheng Wang; Baowei Fei; Luma V Halig; Xulei Qin; Zhongliang Hu; Hong Xu; Yongqiang Andrew Wang; Zhengjia Chen; Sungjin Kim; Dong M Shin; Zhuo Georgia Chen
Journal:  ACS Nano       Date:  2014-07-22       Impact factor: 15.881

5.  Relation of peritubular capillary features to class of lupus nephritis.

Authors:  Sirirat Anutrakulchai; Tanin Titipungul; Thanyaluk Pattay; Putachart Mesung; Anucha Puapairoj; Dhavee Sirivongs; Cholatip Pongsakul; Prasit Futrakul; Bandit Thinkhamrop; Richard J Johnson
Journal:  BMC Nephrol       Date:  2016-11-09       Impact factor: 2.388

6.  Identifying Synergistic Mechanisms of Multiple Ingredients in Shuangbai Tablets against Proteinuria by Virtual Screening and a Network Pharmacology Approach.

Authors:  Xiaoqin Ma; Meixiang Yu; Chenxia Hao; Wanhua Yang
Journal:  Evid Based Complement Alternat Med       Date:  2020-01-06       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.